India Market Entry for US Medical Device Companies

Prepared by AU Corporate's CA-led advisory team · Published 12 October 2026 · General planning guidance; product-specific regulatory advice should be obtained before import or sale.

A US medical device company planning to sell, distribute, service or manufacture products in India needs to plan its commercial model and regulatory pathway together. The first decision is not simply whether to incorporate an Indian company. It is how the product will enter the market, who will hold the relevant permissions, who will import and distribute it, and which entity will employ staff and contract with customers.

1. Define the product and commercial plan

Start with the actual products and planned activities. Different devices, intended uses and risk classes may follow different regulatory pathways. A plan to sell finished devices through an importer is different from a plan to assemble, manufacture, test, service or conduct clinical investigations in India.

• Device name, intended use and classification under the applicable Indian rules.
• Legal manufacturer, actual manufacturing site and product documentation.
• Importing, distribution, marketing, installation, repair and after-sales responsibilities.
• Expected customers, sales channel, pricing, inventory and warranty obligations.
• Whether the company plans to employ local staff, hold inventory or build a long-term India operation.

Do not assume that a US clearance or approval automatically satisfies Indian requirements. Confirm the Indian pathway for each product with a qualified regulatory specialist.

2. Check CDSCO requirements before selecting the entity

Medical devices in India are regulated under the applicable framework, including the Medical Devices Rules, 2017, as amended. Depending on the product and activity, the regulatory process may involve an import licence, manufacturing licence or other requirements. The appropriate pathway should be confirmed for each device and intended activity.

Use the CDSCO Medical Devices Rules page and its Medical Device and Diagnostics resources as official starting points. CDSCO also publishes a Medical Devices Rules FAQ that addresses importers and authorised agents. Confirm the latest documents and rules before filing.

3. Decide who will be the importer or authorised agent

A foreign manufacturer may need an eligible Indian applicant or authorised agent for the relevant import process. The CDSCO FAQ describes an authorised agent as a person or organisation appointed by an overseas manufacturer through a power of attorney to undertake import-related steps in India. The applicant must meet the applicable requirements for the product and licence.

Before appointing an agent or importer, check its current licences or registrations, experience with the relevant product class, quality and complaint-handling procedures, storage and distribution controls, records, and ability to support regulatory updates. The agreement should define who maintains product documentation, reports safety issues, handles recalls, manages changes and supports inspections.

4. Compare distributor-led entry with an Indian subsidiary

A distributor or authorised importer may help a company test demand without immediately establishing a full operating entity. This can reduce the initial local setup burden, but it may also mean less direct control over customer relationships, inventory, pricing, service quality and market information.

An Indian subsidiary may be worth evaluating where the US parent wants its own sales team, service engineers, inventory, customer contracts or broader long-term operations. The subsidiary must still meet applicable foreign-investment, company-law, tax, employment and product-regulatory requirements. Incorporation does not replace a product licence or authorisation.

Compare the models based on product and regulatory responsibilities, expected sales, working capital, local hiring, contract control, service obligations and future plans. If the company only needs to explore demand or use an established distribution network, a partner-led model may be a sensible first step. If it intends to build a lasting local business, model the cost and responsibilities of a subsidiary as well.

5. Review contracts, quality and product responsibilities

Contracts with distributors, importers, service providers and agents should allocate responsibilities clearly. Cover product documentation, permitted territory and channels, storage conditions, training, complaint escalation, adverse-event reporting where applicable, product recalls, audits, records, intellectual property and termination support.

Keep the regulatory and commercial arrangements consistent. A contract should not promise activities that the appointed party is not authorised or equipped to perform. Establish a process to monitor licence validity, regulatory changes, product changes and the status of the actual manufacturing site.

6. Plan the financial and tax model

Build a landed-cost model that includes product price, freight, customs duties and taxes where applicable, local distribution margins, warehousing, service costs, warranty reserves, regulatory work and working capital. The correct customs and tax treatment depends on product classification, transaction structure and current rules.

If an Indian subsidiary transacts with the US parent or other group companies, document product purchases, service fees, royalties, cost recharges and other related-party flows. Review transfer pricing, withholding tax and GST treatment with advisers before pricing agreements or issuing invoices.

7. Set up local operations and recurring compliance

If a subsidiary is established, plan its incorporation, banking, funding, accounting, tax and GST position, payroll, employment terms, company-law filings and foreign-investment reporting where applicable. If a distributor-led model is used, the US parent should still establish a process for monitoring the agent, reviewing commercial records and keeping regulatory documents current.

Allocate responsibilities for customer support, product training, spare parts, service records, warranty claims and complaint escalation. Medical-device market entry involves ongoing responsibilities after the first shipment, so operational ownership should be agreed before launch.

8. Prepare a decision checklist

Before committing to a structure or appointing a partner, prepare a short decision file covering the product list, Indian regulatory pathway, proposed importer or authorised agent, sales forecast, distribution terms, local staffing, expected inventory, tax assumptions and exit plan. Confirm regulatory details directly with qualified advisers and the relevant authorities where needed.

AU Corporate can support the business-structure assessment and coordinate incorporation, accounting, tax and ongoing corporate compliance. Product classification, licensing and regulatory submissions should be handled with appropriately qualified medical-device regulatory specialists.

Official references

• CDSCO: Medical Devices Rules, 2017 and amendments
• CDSCO: Medical Device and Diagnostics resources
• CDSCO: FAQ on Medical Devices Rules
• Ministry of Corporate Affairs for company incorporation and filings.

Frequently asked questions